Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
Nadege T FackcheRyan K SchmockerRichard NudotorBoateng KubiJordan M CloydTravis E GrotzKeith F FournierSean P DineenJula VeerapongJoel M BaumgartnerCallisia N ClarkeSameer H PatelGregory C WilsonLaura A LambertCourtney PokrzywaDaniel E AbbottByrne LeeCharles A StaleyMohammad Y ZaidiFabian M JohnstonJonathan B GreerPublished in: Annals of surgical oncology (2024)
Elevated CA 19-9 is associated with decreased PFS in patients with CRPM. While traditionally CEA is the main tumor marker assessed in colon cancer, we found that CA 19-9 may better inform preoperative risk stratification for poor oncologic outcomes in patients with CRPM. However, prospective studies are required to confirm this association.
Keyphrases
- patients undergoing
- minimally invasive
- protein kinase
- coronary artery bypass
- locally advanced
- rectal cancer
- squamous cell carcinoma
- prostate cancer
- quality improvement
- type diabetes
- adipose tissue
- radical prostatectomy
- radiation therapy
- surgical site infection
- insulin resistance
- coronary artery disease
- acute coronary syndrome
- metastatic renal cell carcinoma